Year archive

ACTINOGEN MEDICAL LIMITED — 2015 filings

All 66 regulatory filings released by ACTINOGEN MEDICAL LIMITED (ACW) in 2015, sourced directly from the official regulator.

66 Filings

2015 Period

2015 filings (66)

Filing	Released	Lang
Investor Update-December 2015 5 pages 2.0MB Investor Presentation	2015-11-30	English
Change of Company Name 1 page 98.6KB Regulatory Filings	2015-11-16	English
Chairman's AGM Address 3 pages 139.9KB AGM Information	2015-11-11	English
CEO's AGM Presentation 20 pages 1.2MB AGM Information	2015-11-11	English
Results of AGM 1 page 98.9KB Declaration of Voting Results & Voting Rights Announcements	2015-11-11	English
Release of Securities from Voluntary Escrow 1 page Capital/Financing Update	2015-11-05	English
Appendix 4C - quarterly 5 pages 85.5KB Interim / Quarterly Report	2015-10-14	English
Understanding Alzheimer's Symposium 2 pages 134.9KB Regulatory Filings	2015-10-06	English
Notice of Annual General Meeting/Proxy Form 20 pages 607.2KB AGM Information	2015-10-06	English
Annual Report to shareholders 78 pages 1.0MB Annual Report	2015-10-06	English
Expiry of Listed Options 1 page 80.4KB Capital/Financing Update	2015-09-29	English
Positive Trial Results for Alzheimers Drug Xanamem 2 pages 159.8KB Capital/Financing Update	2015-09-28	English
Trading Halt 2 pages 378.4KB Regulatory Filings	2015-09-27	English
Appendix 4E & Financial Statements 80 pages 1.2MB Annual Report	2015-08-30	English
Appendix 4G 8 pages 124.6KB Regulatory Filings	2015-08-30	English
Expiry of Listed Options & Waiver of LIsting Rule 6.24 1 Capital/Financing Update	2015-08-30	English
Investor Update-August 2015 5 pages 1.1MB Investor Presentation	2015-08-16	English
Employee Share Plan Vesting Conditions Met 1 page 8 Regulatory Filings	2015-08-11	English
Clinical Trial Successfully Completed with Xanamem 3 pages 118.4KB Regulatory Filings	2015-08-10	English
Employee Share Plan Vesting Conditions Met 1 page 8 Capital/Financing Update	2015-08-10	English
Appendix 4C - quarterly 5 pages 87.2KB Interim / Quarterly Report	2015-07-15	English
Investor Roadshow 21 pages 926.0KB Investor Presentation	2015-07-06	English
Change of Address & Executive Chairman Agreement 2 pages 106.4KB Board/Management Information	2015-06-25	English
Excellent Research Progress with Promising Alzheimers Drug 2 pages 110.7KB Regulatory Filings	2015-06-10	English
ASX Spotlight Series Singapore/Hong Kong May 2015 20 pages 1.0MB Investor Presentation	2015-05-20	English
Employee Share Plan Vesting Conditions Met 1 page 9 Share Issue/Capital Change	2015-05-20	English
Appendix 3B 12 pages 148.0KB Capital/Financing Update	2015-05-19	English
Appendix 3Y-Mr Martin Rogers 2 pages 26.4KB Director's Dealing	2015-05-19	English
Appendix 3Y-Dr Bill Ketelbey 2 pages 24.7KB Director's Dealing	2015-05-19	English
Appendix 3Y-Dr Jason Loveridge 2 pages 26.2KB Director's Dealing	2015-05-19	English
Appendix 3Y-Dr Anton Uvarov 2 pages 24.7KB Director's Dealing	2015-05-19	English
Notice of Change of Interests of Substantial Holder 2 pages 384.2KB Regulatory Filings	2015-05-13	English
Successful Completion of 1st Stage of Alzheimer's Drug Trial 2 pages 111.3KB Regulatory Filings	2015-05-11	English
Ceasing to be a substantial holder 2 pages 572.9KB Regulatory Filings	2015-05-06	English
Change in substantial holding 2 pages 51.1KB Major Shareholding Notification	2015-05-06	English
Appendix 3B 12 pages 149.6KB Capital/Financing Update	2015-05-05	English
Section 708A Notice 1 page 90.5KB Capital/Financing Update	2015-05-05	English
Information Required Under Listing Rule 3.10.5A 1 p Capital/Financing Update	2015-05-05	English
Notice under ASIC Class Order (CO 09/425) 1 page 91 Share Issue/Capital Change	2015-04-30	English
Share Purchase Plan 9 pages 466.8KB Capital/Financing Update	2015-04-29	English
Change in Substantial Shareholding 2 pages 24.6KB Major Shareholding Notification	2015-04-27	English
Change in Substantial Shareholding x 2 4 pages 4.6MB Regulatory Filings	2015-04-26	English
Successful Capital Raising to Support Alzheimers Research 2 pages 134.1KB Capital/Financing Update	2015-04-23	English
Appendix 4C 5 pages 88.9KB Interim / Quarterly Report	2015-04-23	English
Ethics Approval Granted for 2nd Stage of Phase 1 Study 2 pages 109.4KB Regulatory Filings	2015-04-23	English
Trading Halt 2 pages 208.0KB Capital/Financing Update	2015-04-21	English
Xanamem Clinical Advisory Board Conference Call Transcript 2 pages 111.7KB Call Transcript	2015-04-15	English
Further Clinical Trial Update on Xanamem 2 pages 111.9KB Regulatory Filings	2015-04-15	English
Investor Update-April 2015 5 pages 1.9MB Investor Presentation	2015-04-14	English
ACW Investor Presentation-April 2015 20 pages 918.1KB Investor Presentation	2015-04-12	English
EU Patent Granted-Further Extends Xanamem Protection 2 pages 167.3KB Regulatory Filings	2015-04-12	English
Xanamem Clinical Advisory Board Conference Call 2 pages 144.8KB Regulatory Filings	2015-04-12	English
Clinical Trial Update-Xanamem Drug for Alzheimers Dementia 2 pages 108.4KB Regulatory Filings	2015-03-23	English
Powerhouse Alzheimer's Experts to Drive Xanamem Development 3 pages 123.1KB Board/Management Information	2015-03-16	English
Response to Price Query Letter 5 pages 143.9KB Regulatory Filings	2015-03-11	English
Investor Presentation-March 2015 18 pages 824.0KB Investor Presentation	2015-03-08	English
Appendix 4D & Half-Year Financial Statements 30 pages 930.2KB Interim / Quarterly Report	2015-02-26	English
First Participants Recruited for 2nd Phase 1 Xanamem Study 2 pages 111.5KB Regulatory Filings	2015-02-23	English
Employee Share Plan Vesting Conditions Met 1 page 9 Regulatory Filings	2015-02-23	English
Investor Presentation-February 2015 17 pages 1.1MB Investor Presentation	2015-02-16	English
Ethics Approval Granted for Second Phase 1 Study of Xanamem 2 pages 110.6KB Capital/Financing Update	2015-02-15	English
Investor Update-February 2015 8 pages 5.4MB Investor Presentation	2015-02-15	English
Appendix 4C - quarterly 5 pages 92.4KB Interim / Quarterly Report	2015-01-28	English
Employee Share Plan Vesting Conditions Met 1 page 9 Transaction in Own Shares	2015-01-15	English
US Investor Presentation-January 2015 13 pages 1.7MB Investor Presentation	2015-01-08	English
Resonse to ASX Query - Price Query 4 pages 142.1KB Regulatory Filings	2015-01-06	English

Filings by year

2026 45 filings
2025 62 filings
2024 115 filings
2023 69 filings
2022 63 filings
2021 63 filings
2020 50 filings
2019 50 filings
2018 87 filings
2017 68 filings
2016 39 filings
2015 66 filings
2014 50 filings
2013 57 filings
2012 54 filings
2011 39 filings
2010 27 filings
2009 20 filings
2008 29 filings
2007 17 filings